Thus, FBXL19-AS1 might reduce the amount of macrophage M1 to restrain the tumoricidal activity by stabilizing the expression of FBXL19, and then promote the occurrence and development of HCC. This evidence concerns the gene FBXL19 and hepatocellular carcinoma.